RU96111118A - METHOD FOR PRODUCING ALPHA-FETOPROTEIN - Google Patents

METHOD FOR PRODUCING ALPHA-FETOPROTEIN

Info

Publication number
RU96111118A
RU96111118A RU96111118/14A RU96111118A RU96111118A RU 96111118 A RU96111118 A RU 96111118A RU 96111118/14 A RU96111118/14 A RU 96111118/14A RU 96111118 A RU96111118 A RU 96111118A RU 96111118 A RU96111118 A RU 96111118A
Authority
RU
Russia
Prior art keywords
fetoprotein
alpha
producing alpha
solution
reopoliglukin
Prior art date
Application number
RU96111118/14A
Other languages
Russian (ru)
Other versions
RU2121350C1 (en
Inventor
В.В. Стариков
С.Ю. Родионов
В.А. Мягкоходов
С.С. Решетников
Н.А. Пак
Original Assignee
В.В. Стариков
С.Ю. Родионов
Filing date
Publication date
Application filed by В.В. Стариков, С.Ю. Родионов filed Critical В.В. Стариков
Priority to RU96111118A priority Critical patent/RU2121350C1/en
Priority claimed from RU96111118A external-priority patent/RU2121350C1/en
Publication of RU96111118A publication Critical patent/RU96111118A/en
Application granted granted Critical
Publication of RU2121350C1 publication Critical patent/RU2121350C1/en

Links

Claims (3)

1. Способ получения препарата альфа-фетопротеина, включающий растворение активного вещества в воде или в 0,9%-ном растворе натрия хлорида, стерилизующую фильтрацию, фасовку в ампулы или флаконы и лиофильное высушивание, отличающийся тем, что после растворения активного вещества в раствор вводят полисахарид в количестве 4 - 30 мг/мл.1. A method of producing an alpha-fetoprotein preparation, comprising dissolving the active substance in water or in a 0.9% sodium chloride solution, sterilizing filtration, packaging in ampoules or vials, and freeze drying, characterized in that after the active substance is dissolved, the solution is introduced into the solution polysaccharide in an amount of 4-30 mg / ml. 2. Способ по п.1, отличающийся тем, что в качестве полисахарида используют реополиглюкин или полиглюкин. 2. The method according to claim 1, characterized in that as a polysaccharide use reopoliglukin or polyglucin. 3. Способ по п.1, отличающийся тем, что одна ампула лиофилизированного препарата содержит 0,06 - 0,09 мг альфа-фетопротеина и 4 - 30 мг реополиглюкина или полиглюкина. 3. The method according to claim 1, characterized in that one ampoule of the lyophilized preparation contains 0.06 - 0.09 mg of alpha-fetoprotein and 4 - 30 mg of reopoliglukin or polyglucin.
RU96111118A 1996-06-03 1996-06-03 Method of preparing an alpha-fetoprotein preparation RU2121350C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96111118A RU2121350C1 (en) 1996-06-03 1996-06-03 Method of preparing an alpha-fetoprotein preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96111118A RU2121350C1 (en) 1996-06-03 1996-06-03 Method of preparing an alpha-fetoprotein preparation

Publications (2)

Publication Number Publication Date
RU96111118A true RU96111118A (en) 1998-09-27
RU2121350C1 RU2121350C1 (en) 1998-11-10

Family

ID=20181407

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96111118A RU2121350C1 (en) 1996-06-03 1996-06-03 Method of preparing an alpha-fetoprotein preparation

Country Status (1)

Country Link
RU (1) RU2121350C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2448727C2 (en) * 2010-07-01 2012-04-27 Хазеев Ринат Раисович Method of industrial obtaining preparation of alpha-fetoprotein

Similar Documents

Publication Publication Date Title
CA2203961A1 (en) Storage-stable fibrinogen preparations
RU2002106399A (en) MOXIFLOXACIN COMPOSITIONS CONTAINING SODIUM SALT
CA2278759A1 (en) Process for preparing synthetic soil-extract materials and medicaments based thereon
SE8602405D0 (en) NEW FORMULATION
RU96115328A (en) METHOD FOR PRODUCING CREATINE OR CREATINE MONOHYDRATE
SE8702712D0 (en) IMPROVEMENTS IN OR RELATING TO CALCIUM SALTS
RU98119956A (en) CORNERAL STORAGE SOLUTION, INCLUDING HYALURONIC ACID, METHOD FOR STORING CORNERAL TISSUE AND APPLICATION OF THE CORNEAL TISSUE STORAGE
RU93053992A (en) METHOD FOR CLEANING AND STORING FACTOR IX, WATER SOLUTION OF PURIFIED FACTOR IX, COMPOSITION CONTAINING FACTOR IX, METHOD OF TREATMENT
RU96111118A (en) METHOD FOR PRODUCING ALPHA-FETOPROTEIN
KR910000146A (en) Freeze-dried composition and method for preparing the same
ATE55248T1 (en) DRUG COMBINATION.
EA200200383A1 (en) CONTAINING CYCLESONIDE AQUEOUS PHARMACEUTICAL COMPOSITION
RU2000129666A (en) STABLE MITOXANTRON SOLUTIONS
RU2000110741A (en) Parenteral Administration Composition Containing Carbamazepine Or Its Derivatives
RU94037488A (en) METHOD FOR PRODUCING THE MEDICINAL FORM OF THE PRODUCT "CHONDROLON"
RU96124743A (en) OPHTHALMIC MEDICINE
RU98101082A (en) METHOD FOR CLEANING PLASMA PROTEINS FROM LIPOPROTEINS (ITS OPTIONS)
RU2002129337A (en) METHOD FOR PRODUCING BIOMATERIAL FOR USE IN OPHTHALMOLOGY
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
RU99102949A (en) PREPARATION "ANTIGRIPPIN"
RU94030750A (en) Method of preparing mixed medicinal form of penicillin order antibiotics
SU709090A1 (en) Method of preparing apomorphine solution
KR900701263A (en) Ophthalmic pharmaceutical composition comprising a water-soluble acid addition salt of ibopamine
RU97108505A (en) METHOD FOR PRODUCING CHITOZONIUM GLUTAMATE (OPTIONS)
RU96109524A (en) COMPOSITION - MEDICINAL FORM OF ANTI-ARTISTIC MEANS OF GLUCOSAMINE HYDROCHLORIDE FOR INJECTION